Profile
International Journal of Gynecology & Clinical Practices Volume 5 (2018), Article ID 4:IJGCP-139, 3 pages
http://dx.doi.org/10.15344/2394-4986/2018/139
Case Report
Special Issue: Gynecology & Surgical Oncology
Cervical Cancer at a Young Age: Considering Fanconi Anemia as Part of the Clinical Workup

Greta Weaver, Amanda Bruegl, Tanja Pejovic* and Melissa Moffitt

Department of Gynecologic Oncology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA
Dr. Tanja Pejovic, Department of Gynecologic Oncology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA, Tel: 503-418-9382, Fax: 503-418-4048; E-mail: pejovict@ohsu.edu
11 June 2018; 02 August 2018; 04 August 2018
Weaver G, Bruegl A, Pejovic T, Moffitt M (2018) Cervical Cancer at a Young Age: Considering Fanconi Anemia as Part of the Clinical Workup. Int J Gynecol Clin Pract 5: 139. doi: http://dx.doi.org/10.15344/2394-4986/2018/139

Abstract

Background: Fanconi Anemia is a rare condition that carries an increased risk of squamous cell carcinoma of the head, neck and cervix due to mutations in DNA repair pathways. These same mutations may also be associated with intrinsic treatment resistance (FANCD2) and hypersensitivity (FANCA).
Case: A 22-year-old woman with a history of anemia who presented with rapid progression to squamous cell carcinoma of the cervix. She developed aplastic anemia during chemoradiation and was subsequently diagnosed with Fanconi Anemia.
Conclusion: Rare conditions such as Fanconi Anemia should be considered when the clinical course varies significantly from the norm. Consultations with hematology and genetics may elucidate other possible contributing factors. HPV vaccination remains an underutilized method for primary prevention of cervical cancer and should be promoted among eligible populations.